mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to target a patient’s unique cancer […]
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say Read Post »






